198 related articles for article (PubMed ID: 20863373)
1. Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma.
Kraus TS; Cohen C; Siddiqui MT
Diagn Pathol; 2010 Sep; 5():63. PubMed ID: 20863373
[TBL] [Abstract][Full Text] [Related]
2. Expression of androgen receptor and prostate-specific antigen in male breast carcinoma.
Kidwai N; Gong Y; Sun X; Deshpande CG; Yeldandi AV; Rao MS; Badve S
Breast Cancer Res; 2004; 6(1):R18-23. PubMed ID: 14680496
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of prostate-specific antigen in ductal epithelium of male breast. Potential diagnostic pitfall in patients with gynecomastia.
Gatalica Z; Norris BA; Kovatich AJ
Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):158-61. PubMed ID: 10937064
[TBL] [Abstract][Full Text] [Related]
4. NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
[TBL] [Abstract][Full Text] [Related]
5. Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast.
Magro G; Bisceglia M; Michal M
Histopathology; 2000 Jun; 36(6):515-21. PubMed ID: 10849093
[TBL] [Abstract][Full Text] [Related]
6. Steroid hormone receptors in male breast diseases.
Pacheco MM; Oshima CF; Lopes MP; Widman A; Franco EL; Brentani MM
Anticancer Res; 1986; 6(5):1013-7. PubMed ID: 3026231
[TBL] [Abstract][Full Text] [Related]
7. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
8. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
9. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study.
Sasano H; Kimura M; Shizawa S; Kimura N; Nagura H
J Clin Endocrinol Metab; 1996 Aug; 81(8):3063-7. PubMed ID: 8768875
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age.
Yu H; Diamandis EP; Sutherland DJ
Clin Biochem; 1994 Apr; 27(2):75-9. PubMed ID: 7520846
[TBL] [Abstract][Full Text] [Related]
11. Lack of relationship between the expression of Hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma.
Muñoz de Toro MM; Luque EH
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):277-84. PubMed ID: 9219918
[TBL] [Abstract][Full Text] [Related]
12. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
[TBL] [Abstract][Full Text] [Related]
13. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.
Takuwa H; Tsuji W; Shintaku M; Yotsumoto F
BMC Cancer; 2018 Dec; 18(1):1282. PubMed ID: 30577860
[TBL] [Abstract][Full Text] [Related]
14. Metastatic prostatic adenocarcinoma within a primary solid papillary carcinoma of the male breast.
Sahoo S; Smith RE; Potz JL; Rosen PP
Arch Pathol Lab Med; 2001 Aug; 125(8):1101-3. PubMed ID: 11473469
[TBL] [Abstract][Full Text] [Related]
15. Male breast cancer: Looking for better prognostic subgroups.
Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
[TBL] [Abstract][Full Text] [Related]
16. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature.
Fan CY; Wang J; Barnes EL
Am J Surg Pathol; 2000 Apr; 24(4):579-86. PubMed ID: 10757407
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer.
Parwani AV; Marlow C; Demarzo AM; Mikolajczyk SD; Rittenhouse HG; Veltri RW; Chan TY
Am J Surg Pathol; 2006 Oct; 30(10):1231-6. PubMed ID: 17001152
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
20. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
